BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28299467)

  • 1. Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.
    Dassanayaka S; Brainard RE; Watson LJ; Long BW; Brittian KR; DeMartino AM; Aird AL; Gumpert AM; Audam TN; Kilfoil PJ; Muthusamy S; Hamid T; Prabhu SD; Jones SP
    Basic Res Cardiol; 2017 May; 112(3):23. PubMed ID: 28299467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte Ogt is essential for postnatal viability.
    Watson LJ; Long BW; DeMartino AM; Brittian KR; Readnower RD; Brainard RE; Cummins TD; Annamalai L; Hill BG; Jones SP
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(1):H142-53. PubMed ID: 24186210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.
    Watson LJ; Facundo HT; Ngoh GA; Ameen M; Brainard RE; Lemma KM; Long BW; Prabhu SD; Xuan YT; Jones SP
    Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17797-802. PubMed ID: 20876116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
    Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
    J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Matsuno M; Yokoe S; Nagatsuka T; Morihara H; Moriwaki K; Asahi M
    Front Endocrinol (Lausanne); 2023; 14():1122125. PubMed ID: 37033243
    [No Abstract]   [Full Text] [Related]  

  • 7. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. αSMA-Cre-mediated Ogt deletion leads to heart failure and vascular smooth muscle cell dysfunction in mice.
    Xiong X; Ma H; Ma J; Wang X; Li D; Xu L
    Biochem Biophys Res Commun; 2022 Oct; 625():31-37. PubMed ID: 35944361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
    Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
    Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive
    Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
    Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    Dassanayaka S; Brittian KR; Long BW; Higgins LA; Bradley JA; Audam TN; Jurkovic A; Gumpert AM; Harrison LT; Hartyánszky I; Perge P; Merkely B; Radovits T; Hanover JA; Jones SP
    PLoS One; 2020; 15(11):e0242250. PubMed ID: 33253217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular O-linked glycosylation directly regulates cardiomyocyte L-type Ca
    Ednie AR; Bennett ES
    Basic Res Cardiol; 2020 Sep; 115(6):59. PubMed ID: 32910282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Increases in Cardiomyocyte Protein
    Ha CM; Bakshi S; Brahma MK; Potter LA; Chang SF; Sun Z; Benavides GA; He L; Umbarkar P; Zou L; Curfman S; Sunny S; Paterson AJ; Rajasekaran NS; Barnes JW; Zhang J; Lal H; Xie M; Darley-Usmar VM; Chatham JC; Wende AR
    J Am Heart Assoc; 2023 Oct; 12(19):e029898. PubMed ID: 37750556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.
    Ikeda S; Mizushima W; Sciarretta S; Abdellatif M; Zhai P; Mukai R; Fefelova N; Oka SI; Nakamura M; Del Re DP; Farrance I; Park JY; Tian B; Xie LH; Kumar M; Hsu CP; Sadayappan S; Shimokawa H; Lim DS; Sadoshima J
    Circ Res; 2019 Jan; 124(2):292-305. PubMed ID: 30582455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy.
    Papanicolaou KN; Jung J; Ashok D; Zhang W; Modaressanavi A; Avila E; Foster DB; Zachara NE; O'Rourke B
    J Biol Chem; 2023 Mar; 299(3):102907. PubMed ID: 36642184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca
    Korf-Klingebiel M; Reboll MR; Polten F; Weber N; Jäckle F; Wu X; Kallikourdis M; Kunderfranco P; Condorelli G; Giannitsis E; Kustikova OS; Schambach A; Pich A; Widder JD; Bauersachs J; van den Heuvel J; Kraft T; Wang Y; Wollert KC
    Circulation; 2021 Oct; 144(15):1227-1240. PubMed ID: 34372689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAcylation Is Essential for Autophagy in Cardiomyocytes.
    Yu H; Wen L; Mu Y
    Oxid Med Cell Longev; 2020; 2020():5602396. PubMed ID: 32850000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.